894 related articles for article (PubMed ID: 27212418)
21. [Neurofibromatosis 1].
Yoshida Y
Brain Nerve; 2019 Apr; 71(4):368-372. PubMed ID: 30988223
[TBL] [Abstract][Full Text] [Related]
22. Mutational spectrum by phenotype: panel-based NGS testing of patients with clinical suspicion of RASopathy and children with multiple café-au-lait macules.
Castellanos E; Rosas I; Negro A; Gel B; Alibés A; Baena N; Pineda M; Pi G; Pintos G; Salvador H; Lázaro C; Blanco I; Vilageliu L; Brems H; Grinberg D; Legius E; Serra E
Clin Genet; 2020 Feb; 97(2):264-275. PubMed ID: 31573083
[TBL] [Abstract][Full Text] [Related]
23. Challenges in the diagnosis of neurofibromatosis type 1 (NF1) in young children facilitated by means of revised diagnostic criteria including genetic testing for pathogenic NF1 gene variants.
Kehrer-Sawatzki H; Cooper DN
Hum Genet; 2022 Feb; 141(2):177-191. PubMed ID: 34928431
[TBL] [Abstract][Full Text] [Related]
24. A novel NF1 mutation in a Chinese patient with giant café-au-lait macule in neurofibromatosis type 1 associated with a malignant peripheral nerve sheath tumor and bone abnormality.
Tong HX; Li M; Zhang Y; Zhu J; Lu WQ
Genet Mol Res; 2012 Aug; 11(3):2972-8. PubMed ID: 22869071
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive RNA Analysis of the NF1 Gene in Classically Affected NF1 Affected Individuals Meeting NIH Criteria has High Sensitivity and Mutation Negative Testing is Reassuring in Isolated Cases With Pigmentary Features Only.
Evans DG; Bowers N; Burkitt-Wright E; Miles E; Garg S; Scott-Kitching V; Penman-Splitt M; Dobbie A; Howard E; Ealing J; Vassalo G; Wallace AJ; Newman W; ; Huson SM
EBioMedicine; 2016 May; 7():212-20. PubMed ID: 27322474
[TBL] [Abstract][Full Text] [Related]
26. Segmental neurofibromatosis in childhood.
Listernick R; Mancini AJ; Charrow J
Am J Med Genet A; 2003 Aug; 121A(2):132-5. PubMed ID: 12910491
[TBL] [Abstract][Full Text] [Related]
27. Jaffe-Campanacci syndrome, revisited: detailed clinical and molecular analyses determine whether patients have neurofibromatosis type 1, coincidental manifestations, or a distinct disorder.
Stewart DR; Brems H; Gomes AG; Ruppert SL; Callens T; Williams J; Claes K; Bober MB; Hachen R; Kaban LB; Li H; Lin A; McDonald M; Melancon S; Ortenberg J; Radtke HB; Samson I; Saul RA; Shen J; Siqveland E; Toler TL; van Maarle M; Wallace M; Williams M; Legius E; Messiaen L
Genet Med; 2014 Jun; 16(6):448-59. PubMed ID: 24232412
[TBL] [Abstract][Full Text] [Related]
28. Ectropion Uveae in neurofibromatosis type 1: a new manifestation.
Iacovino C; Miraglia E; Moramarco A; Corbo G; Lambiase A; Giustini S
Clin Ter; 2021 May; 172(3):206-208. PubMed ID: 33956037
[TBL] [Abstract][Full Text] [Related]
29. Family with Legius syndrome (neurofibromatosis type 1-like syndrome).
Sakai N; Maeda T; Kawakami H; Uchiyama M; Harada K; Tsuboi R; Mitsuhashi Y
J Dermatol; 2015 Jul; 42(7):703-5. PubMed ID: 25981987
[TBL] [Abstract][Full Text] [Related]
30. Phenotypic variability among café-au-lait macules in neurofibromatosis type 1.
Boyd KP; Gao L; Feng R; Beasley M; Messiaen L; Korf BR; Theos A
J Am Acad Dermatol; 2010 Sep; 63(3):440-7. PubMed ID: 20605257
[TBL] [Abstract][Full Text] [Related]
31. Cutaneous Manifestations not Considered Diagnostic Criteria for Neurofibromatosis Type 1. A Case-Control Study.
García-Martínez FJ; Duat-Rodríguez A; Andrés Esteban E; Torrelo A; Noguera Morel L; Hernández-Martín A
Actas Dermosifiliogr; 2022; 113(10):923-929. PubMed ID: 35636506
[TBL] [Abstract][Full Text] [Related]
32. Value of a café-au-lait macules screening clinic: Experience from The Hospital for Sick Children in Toronto.
Albaghdadi M; Berseneva M; Pennal A; Wan S; Matviychuk D; Shugar A; Kannu P; Lara-Corrales I
Pediatr Dermatol; 2022 Mar; 39(2):205-210. PubMed ID: 35178768
[TBL] [Abstract][Full Text] [Related]
33. Partial unilateral lentiginosis is mosaic neurofibromatosis type 1 or not?
Yaşar Ş; Ersanli A; Göktay F; Aytekin S; Cebeci D; Güneş P
J Dermatol; 2017 Jan; 44(1):29-35. PubMed ID: 27439996
[TBL] [Abstract][Full Text] [Related]
34. [Genetic diagnosis of a child with Café-au-lait macules and juvenile xanthogranuloma].
Lu X; Xiao F
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Nov; 39(11):1266-1269. PubMed ID: 36317216
[TBL] [Abstract][Full Text] [Related]
35. Giant café-au-lait macule in neurofibromatosis 1: a type 2 segmental manifestation of neurofibromatosis 1?
Yang CC; Happle R; Chao SC; Yu-Yun Lee J; Chen W
J Am Acad Dermatol; 2008 Mar; 58(3):493-7. PubMed ID: 18280349
[TBL] [Abstract][Full Text] [Related]
36. Multiple café au lait macules and Crowe sign.
López Aventín D; Gilaberte M; Pujol RM
Arch Dermatol; 2011 Jun; 147(6):735-40. PubMed ID: 21690543
[No Abstract] [Full Text] [Related]
37. [Anxiety disorders in type 1 neurofibromatosis: A case report].
Fekih-Romdhane F; Othman S; Sahnoun C; Helayem S; Abbes Z; Bouden A
Arch Pediatr; 2015 Sep; 22(9):956-60. PubMed ID: 26228808
[TBL] [Abstract][Full Text] [Related]
38. Familial café au lait spots: a variant of neurofibromatosis type 1.
Abeliovich D; Gelman-Kohan Z; Silverstein S; Lerer I; Chemke J; Merin S; Zlotogora J
J Med Genet; 1995 Dec; 32(12):985-6. PubMed ID: 8825931
[TBL] [Abstract][Full Text] [Related]
39. Familial café-au-lait macules associated with in-frame deletion of NF1 p.Met992del mimicking Legius syndrome.
Nakato D; Yamada M; Suzuki H; Takenouchi T; Kosaki K
Congenit Anom (Kyoto); 2023 Mar; 63(2):54-55. PubMed ID: 36637081
[No Abstract] [Full Text] [Related]
40. Café au Lait Macules and Associated Genetic Syndromes.
Anderson S
J Pediatr Health Care; 2020; 34(1):71-81. PubMed ID: 31831114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
